BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 996 filers reported holding BAXTER INTL INC in Q2 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $594,000 | +117.6% | 7,044 | +111.0% | 0.03% | +75.0% |
Q2 2019 | $273,000 | -2.8% | 3,339 | -3.5% | 0.02% | -11.1% |
Q1 2019 | $281,000 | +23.2% | 3,459 | 0.0% | 0.02% | +12.5% |
Q4 2018 | $228,000 | -14.3% | 3,459 | 0.0% | 0.02% | 0.0% |
Q3 2018 | $266,000 | +9.5% | 3,459 | +5.4% | 0.02% | +6.7% |
Q2 2018 | $243,000 | +6.6% | 3,282 | -6.5% | 0.02% | 0.0% |
Q1 2018 | $228,000 | -18.3% | 3,512 | -18.6% | 0.02% | -16.7% |
Q4 2017 | $279,000 | -5.1% | 4,317 | -7.9% | 0.02% | -5.3% |
Q3 2017 | $294,000 | +1.0% | 4,688 | -2.5% | 0.02% | 0.0% |
Q2 2017 | $291,000 | +14.1% | 4,808 | -2.4% | 0.02% | +11.8% |
Q1 2017 | $255,000 | -7.9% | 4,927 | -21.3% | 0.02% | -15.0% |
Q4 2016 | $277,000 | -8.9% | 6,259 | -2.1% | 0.02% | -9.1% |
Q3 2016 | $304,000 | -0.7% | 6,396 | -5.5% | 0.02% | -4.3% |
Q2 2016 | $306,000 | +8.1% | 6,766 | -1.9% | 0.02% | +9.5% |
Q1 2016 | $283,000 | -33.3% | 6,896 | -38.1% | 0.02% | -34.4% |
Q4 2015 | $424,000 | -37.3% | 11,135 | -46.0% | 0.03% | -39.6% |
Q3 2015 | $676,000 | -75.4% | 20,604 | -47.6% | 0.05% | -65.4% |
Q2 2015 | $2,748,000 | -32.7% | 39,298 | -34.1% | 0.15% | -15.9% |
Q1 2015 | $4,083,000 | -6.9% | 59,610 | -0.4% | 0.18% | -8.5% |
Q4 2014 | $4,386,000 | +4.1% | 59,836 | +2.0% | 0.20% | +5.9% |
Q3 2014 | $4,212,000 | +1.8% | 58,688 | +2.6% | 0.19% | +4.4% |
Q2 2014 | $4,136,000 | +2.5% | 57,207 | +4.3% | 0.18% | -2.2% |
Q1 2014 | $4,034,000 | +3.4% | 54,832 | -2.3% | 0.18% | +8.2% |
Q4 2013 | $3,902,000 | +5.2% | 56,106 | -0.6% | 0.17% | -4.0% |
Q3 2013 | $3,709,000 | -7.1% | 56,464 | -2.1% | 0.18% | -12.4% |
Q2 2013 | $3,993,000 | – | 57,649 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |